Covalent modalities: covalent drugs 19/03/2024
Scientific Programme:
- Welcome & Introduction Jean-Yves Ortholand (SCT & Edelris, Lyon, FR), Rebecca Deprez-Poulain (SCT & Univ. Lille, FR)
- Simona COTESTA, Novartis, Basel. Identification and Optimization of a Novel Class of KRASG12C Inhibitors, Leading to the Discovery of JDQ443
- Chao ZHANG, University of Southern California, LA, USA. Use of Latent Warheads for Covalent Drugging
- Closing remarks